Click image to enlarge
The Rat Demonstration 7-Plex Ultra-Sensitive Kit provides assay-specific components for the simultaneous quantitative determination of both natural and recombinant rat IFN-γ, IL- 1β, IL-4, IL-5, IL-13, KC/GRO/CINC, and TNF-α in tissue culture supernatant.
-
-
Specifications
-
-
Documentation
-
References
|
Application(s)
|
|
Cytokines & Chemokines
,
Immunology/Inflammation
|
|
|
Analyte(s)
|
|
IFN-γ, IL-1β, IL-4, IL-5, IL-13, KC/GRO, TNF-α
|
|
|
Species
|
|
Rat
|
|
|
Plate Type
|
|
96-well
|
|
|
Instrument(s)
|
|
MESO SECTOR S 600MM
,
MESO QuickPlex SQ 120MM
,
MESO SECTOR S 600
,
MESO QuickPlex SQ 120
,
SECTOR Imager 6000
,
SECTOR Imager 2400
|
|
|
Capture Antibody
|
|
IFN-γ: Mouse Monoclonal
IL-1β: Mouse Monoclonal
IL-4: Mouse Monoclonal
IL-5: Rat Monoclonal
KC/GRO: Rabbit Polyclonal
IL-13: Goat Polyclonal
TNF-α: Hamster Monoclonal
|
|
|
Detection Antibody
|
|
IFN-γ: Goat Polyclonal
IL-1β: Goat Polyclonal
IL-4: Goat Polyclonal
IL-5: Rat Monoclonal
KC/GRO: Goat Polyclonal
IL-13: Goat Polyclonal
TNF-α: Goat Polyclonal
|
|
|
LLOD (Sensitivity)
|
|
IFN-γ: 9.0 pg/mL
IL-1β: 25 pg/mL
IL-4: 1.6 pg/mL
IL-5: 25 pg/mL
KC/GRO: 8.3 pg/mL
IL-13: 3.4 pg/mL
TNF-α: 54 pg/mL
|
|
|
Dynamic Range
|
|
IFN-γ: 9.0-40000 pg/mL
IL-1β: 25-40000 pg/mL
IL-4: 1.6-40000 pg/mL
IL-5: 25-40000 pg/mL
KC/GRO: 8.3-40000 pg/mL
IL-13: 3.4-40000 pg/mL
TNF-α: 54-40000 pg/mL
|
|
|
Sample Type
|
|
Serum, Plasma
|
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
|
Storage Statement(s)
|
|
Please refer to the product insert for the storage conditions of individual kit components.
|
|
|
Storage Condition
|
|
Multi-Component
|
|
|
Product Inserts
|
|
|
|
Datasheets
|
|
|
|
SDS
|
|
|
|
Title
|
Journal
|
Year
|
|
A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma
|
|
|
|
Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke
|
|
|
|
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms
|
|
|
|
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations
|
|
|
|
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
|
|
|
|
|
View All
|
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters